# US 2012/0253018 A1 · Bovine Adeno-Associated Viral (BAAV) Vector and Uses Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253018 A1
- Document ID: US20120253018A1
- Status: Published application
- Kind: A1
- Application number: 13/413,321
- Filed: 2012-03-06
- Published: 2012-10-04
- Earliest claimed: 2003-12-04
- Assignees: Human Services; The United States of America, as represented by the Secretary, Department of Health and
- Inventors: John A. Chiorini; Michael Schmidt; Ioannis Bossis; Giovanni Di Pasquale
- Web page: https://patentgrep.com/patent/US20120253018A1

## CPC

- C07K 14/005: from viruses
- A61K 48/0075: {characterised by an aspect of the delivery route, e.g. oral, subcutaneous}
- A61K 48/0091: {Purification or manufacturing processes for gene therapy compositions}
- C07K 16/081: DNA viruses
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 15/86: Viral vectors
- G01N 33/56983: {Viruses}
- C12N 2750/14121: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2750/14122: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides a bovine adeno-associated virus (BAAV) virus and vectors and particles derived therefrom. In addition, the present invention provides methods of delivering a nucleic acid to a cell using the BAAV vectors and particles.

## Claims

### Claim at position 1

1-108. (canceled)

### Claim 109

An isolated nucleic acid molecule comprising a nucleic acid sequence encoding a polypeptide selected from the group consisting of:
a) a polypeptide comprising a unique fragment of an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11;
b) a polypeptide comprising an amino acid sequence at least 80% identical over the entire length of an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11.

### Claim 110 (depends on 109)

The isolated nucleic acid molecule of claim 109, wherein the encoded polypeptide has at least one activity selected from the group consisting of a) binding an antibody selective for a polypeptide consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 or SEQ ID NO:11; and b) combining with other capsid proteins to form a BAAV particle.

### Claim 111 (depends on 109)

The isolated nucleic acid molecule of claim 109, wherein the encoded polypeptide comprises:
i) at least one epitope from a sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11;
ii) at least one sequence selected from the group consisting of SEQ ID NO:18 and SEQ ID NO:19;
iii) at least 40 contiguous amino acids from a sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11; or,
iv) at least 100 contiguous amino acids from a sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11.

### Claim 112 (depends on 109)

The isolated nucleic acid molecule of claim 109, wherein the amino acid sequence of the encoded polypeptide differs from an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11 as a result of one or more conservative substitutions.

### Claim 113 (depends on 109)

The isolated nucleic acid molecule of claim 109, wherein the encoded polypeptide comprises:
i) an amino acid sequence at least 90% identical over the entire length of an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11;
ii) an amino acid sequence at least 95% identical over the entire length of an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11; or,
iii) an amino acid sequence at least 97% identical over the entire length of an amino acid sequence selected from the group consisting of SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11, and wherein the differences between the amino acid sequence of the encoded protein and a sequence selected from the group consisting of SEQ ID NO:7, SEQ ID NO:9 or SEQ ID NO:11 are confined at least one region corresponding to a region selected from the group consisting of A) amino acids 257-264 of SEQ ID NO:7; and B) amino acids 444-457 of SEQ ID NO:7.

### Claim 114 (depends on 109)

The isolated nucleic acid molecule of claim 109, wherein the encoded polypeptide comprises a sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11.

### Claim 115 (depends on 109)

The isolated nucleic acid molecule of claim 109, wherein the nucleic acid sequence comprises:
i) at least 30 contiguous nucleotides from a sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 and SEQ ID NO:10; or
ii) at least contiguous 100 nucleotides from a sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 and SEQ ID NO:10.

### Claim 116 (depends on 109)

The isolated nucleic acid molecule of claim 109, wherein the nucleic acid sequence comprises a polynucleotide sequence at least 90% identical to a sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 and SEQ ID NO:10.

### Claim 117 (depends on 109)

The isolated nucleic acid molecule of claim 109, wherein the nucleic acid sequence comprises a sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 and SEQ ID NO:10.

### Claim 118

An isolated protein selected from the group consisting of:
a) an isolated protein comprising a unique fragment of an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11; and
b) an isolated protein comprising an amino acid sequence at least 80% identical over the entire length of an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11.

### Claim 119 (depends on 118)

The isolated protein of claim 118, wherein the protein has at least one activity selected from the group consisting of i) binding an antibody selective for a polypeptide consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 or SEQ ID NO:11; and ii) combining with other capsid proteins to form a BAAV particle.

### Claim 120 (depends on 118)

The isolated protein of claim 118, wherein the protein comprises:
i) at least one epitope from a sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11;
ii) at least one sequence selected from the group consisting of SEQ ID NO:18 and SEQ ID NO:19;
iii) at least 40 contiguous amino acids from a sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11; or
iv) at least 100 contiguous amino acids from a sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11.

### Claim 121 (depends on 118)

The isolated protein of claim 118, wherein the amino acid sequence of the protein differs from an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11 as a result of one or more conservative substitutions.

### Claim 122 (depends on 118)

The isolated protein of claim 118, wherein the protein comprises:
i) an amino acid sequence at least 90% identical over the entire length of an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11;
ii) an amino acid sequence at least 95% identical over the entire length of an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11; or,
iii) an amino acid sequence at least 97% identical over the entire length of an amino acid sequence selected from the group consisting of SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11, and wherein the differences between the amino acid sequence of the protein and an amino acid sequence selected from the group consisting of SEQ ID NO:7, SEQ ID NO:9 are SEQ ID NO:11 are confined to at least one region corresponding to a region selected from the group consisting of A) amino acids 257-264 of SEQ ID NO:7; and B) amino acids 444-457 of SEQ ID NO:7.

### Claim 123 (depends on 118)

The isolated protein of claim 118, wherein the protein comprises an amino acid sequence selected from the group consisting of SEQ ID NO:3 and SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11.

### Claim 124 (depends on 118)

The isolated protein of claim 118, wherein the protein is encoded by a nucleic acid sequence comprising:
i) at least 30 contiguous nucleotides from a sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 and SEQ ID NO:10; or,
ii) at least contiguous 100 nucleotides from a sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 and SEQ ID NO:10.

### Claim 125 (depends on 118)

The isolated protein of claim 118, wherein the protein is encoded by a nucleic acid sequence at least 90% identical to a sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 and SEQ ID NO:10.

### Claim 126 (depends on 118)

The isolated protein of claim 118, wherein the protein is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 and SEQ ID NO:10.

### Claim 127 (depends on 118)

An isolated antibody that selectively binds the isolated protein of claim 118.
